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The objective of this study will be to establish, validate, and characterize a dry
eye model in female rats induced by continuous systemic administration of
scopolamine via Alzet® osmotic pumps for 28 days. This study will use female rats as
a model for dry eye and will be implanted with osmotic pumps that will continuously
distribute scopolamine or saline systemically over 28 days. Scopolamine will be used

to induce the dry eye condition and saline will be used as a negative control.

The

clinical signs of dry eye will be evaluated by tear volume measurements with sterilized
phenol-red thread (FCI Opthalmics Zone Quick™), corneal staining with 0.2% sodium
fluorescein (Novartis Pharmaceutials), and corneal thickness measurements. Ocular
coherence tomography (OCT) images of the central cornea will be collected with the

Spectralis HRA+OCT (Heidelberg Engineering) to measure thickness and corneal
staining will be evaluated using a photographic slit lamp under cobalt blue light

(Heidelberg Engineering). Topical medications currently available to treat dry eye will
be used in the second phase of the study to validate that the condition is induced and

confirm healing. This study will aid in understanding the unique characteristics of dry
eye and its limitations to help provide further insight into the development of more
effective therapeutic solutions of the condition.
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SPECIFIC AIMS

The objective of this study will be to establish, validate, and characterize a dry
eye model in female rats induced by continuous systemic administration of
scopolamine via Alzet® osmotic pumps for 28 days.

Dry eye syndrome or

keratoconjunctivitis sicca (KCS) is a common ocular disease affecting between 7%
and 15% of the female population over the age of 50 in the United States (1). The
cornea, conjunctiva, and lacrimal glands comprise the lacrimal functional unit and
work together to regulate tear production and character (1).

During dry eye, any

component of this unit may become inflamed leading to the chronic ocular surface
damage that characterizes this condition (1).

Artificial tears offer relief to those suffering from dry eye by improving the
symptoms but do not treat the underlying causes that lead to chronic inflammation (2).

The key component of pathogenesis in dry eye is inflammation of the ocular surface

and, thus, it is the main target for therapy (2). For example, topical administration of
cyclosporin A, an immunomodulatory drug, decreases the inflammatory state of the
conjunctiva and accelerates the recovery of the conjunctival goblet cells (2).

Comparative animal models of dry eye have been developed to reproduce the

pathophysiological effects of this condition (3). This study will use female rats as a

model for dry eye and will be implanted with osmotic pumps that will continuously
distribute scopolamine or saline systemically over 28 days. Scopolamine will be used
to induce the dry eye condition and saline will be used as a negative control. The
clinical signs of dry eye will be evaluated by tear volume measurements with sterilized

phenol-red thread (FCI Opthalmics Zone Quick™), corneal staining with 0.2% sodium
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fluorescein (Novartis Pharmaceutials), and corneal thickness measurements. Ocular

coherence tomography (OCT) images of the central cornea will be collected with the

Spectralis HRA+OCT (Heidelberg Engineering) to measure thickness and corneal
staining will be evaluated using a photographic slit lamp under cobalt blue light
(Heidelberg Engineering).

The main objective of this study is to understand the unique characteristics of

dry eye and its limitations to help provide further insight into the development of more
effective therapeutic solutions of the condition. If we successfully induce dry eye, then

the diagnostic methods used to measure ocular dryness will indicate that the condition
has been simulated and healing will occur using available topical medications. The
three specific aims of this study are:
1. To establish the dry eye condition.

2. Identify symptoms of dry eye using ocular imaging.

3. Confirm that healing can be seen after application of topical medications
available to treat dry eye.

The results of this study will provide proven clinical diagnostic procedures to

identify dry eye, which topical therapies are most effective in treating the condition,
and make a contribution in the field of dry eye study.

INTRODUCTION

Background and Significance

The eyes are a vital sensory organ and provide animals with the sense of sight.
The eyes are used to survey the environment and relay sensory information to the
brain. Light is one of the most useful signals in the environment and the ability to
detect it is, therefore, one of the most useful senses to animals (4). Light from an

observed object is focused by the cornea and lens onto the photoreceptive retina at the

back of the eye. The focus is maintained on the retina at different distances between
the object and the eyes by muscular contractions that change the thickness and degree
of curvature of the lens (5). When the light reaches the retina, a signal is sent to the

brain via the optic nerve where it is further processed and where visual perception
occurs.

Many different cellular structures help provide rigidity to the organ and
maintain the overall health of the tissues. The outermost layer of the eye is a tough
coat of connective tissue called the sclera, which can be externally seen as the white of

the eyes (5). The tissue of the sclera is continuous with the transparent cornea. Light
passes through the cornea to enter the anterior chamber of the eye. Light then passes
through an opening called the pupil, which is surrounded by a pigmented muscle,
known as the iris. After passing through the pupil, light enters the lens, passes through
the vitreous chamber, and is focused onto the retina (5).

These are the main

anatomical structures of the eye and are important for photoreception but they do not
function in maintaining the integrity of the tear film and keeping the ocular surface
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lubricated.

These important functions are the responsibility of the tissues that

comprise the lacrimal functional unit.
In order to maintain ocular surface homeostasis, the appropriate release in

quantity and composition of tear film components must occur in response to various
stimuli.

Secretion of tear film components is coordinated and controlled by the

lacrimal functional unit. The lacrimal functional unit is composed of the ocular surface

tissues, the cornea and conjunctiva, the lacrimal glands (main and accessory), and their
interconnecting sensory and autonomic innervation (Cranial Nerves V and VII) (6).
Innervation of the lacrimal functional unit occurs from the parasympathetic and

sympathetic nerve systems, and sensory fibers from the trigeminal nerve (6).
The cornea protects the delicate intraocular contents with its tough, yet pliable,

collagen structure (6). It has the ability to resist injury and provide the essential optics
and transparency to focus an image on the retina.

The anterior corneal surface

becomes slightly flatter in the periphery, giving the overall cornea a naturally rounded
shape. If the cornea were perfectly spherical, it would suffer from a considerable
spherical irregularity in which the light passing through the peripheral parts of an
optical system do not come to the same focal point as the light near the central axis of
the system (6).

Peripheral corneal flattening reduces the corneal contribution of

spherical irregularity to the optical system of the eye. The lens provides additional
correction of the residual spherical irregularity of the cornea.

The cornea protrudes slightly beyond the limits of the scleral globe because of
the difference in curvature between the relatively steep cornea and the relatively flat
globe (6). A shallow sulcus is formed at the intersection of the corneal and scleral

surfaces, which roughly defines a region called the limbus. The histologic limbus is the
full-thickness annular boundary that separates the optically transparent corneal stroma
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from the opaque sclera (6).

The corneal epithelium is the anterior-most cell layer of the cornea. It is

typically several cell layers thick, consisting of the apical squamous cell layer, the
multilayered, polygonal-shaped wing cells beneath the apical layer, and the posteriormost layer of basal cells (6). The wing cell layer is two or three cells thick in the
central cornea, but tends to be four to five cells thick in the periphery. The two major

properties of the corneal epithelium needed for normal vision are to form a smooth
refractive surface via its interaction with the tear film and to form a protective tight

junctional barrier that prevents decreases in net fluid transport out from the stroma and

prevents corneal penetration by pathogens (7). To provide the epithelial barrier
function, epithelial cells are specialized to form tight adherences between one another
and to the basal lamellae. The cells from the basal layer migrate into the suprabasal

layers and undergo differentiation.

The superficial cells possess tight junctions,

zonulae occludens, which serve as a semipermeable, highly resistive membrane (7). As

the superficial differentiated cells are lost, they are replaced by the underlying
proliferating basal cell layer. Following their emergence, the newly formed cells
migrate first from the basal layer into the upper differentiating wing layers and then
into the superficial layers. It is of paramount importance that the differentiating cells
are able to re-establish the tight junctional physical barrier that protects the cornea
interior from noxious agents, e.g., microorganism infections, as the epithelial cell
layers are interconnected via desmosomes and communicate with one another via gap

junctions, especially in the wing cell layer.

Therefore, through the processes of

mitosis, migration, and shedding, the cornea epithelium is well maintained (7). The
Bowman's membrane lies just beneath the epithelium. Because this layer is very tough
and difficult to penetrate, it protects the cornea from injury. It is located between the
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superficial epithelium and the stroma in the cornea. It is composed of strong collagen
fibers and helps the cornea maintain its shape. In total, the epithelium is approximately
50 micrometers (urn) thick in the central human cornea (7).

The epithelium is in a constant state of turnover, with exfoliating apical cells

being replaced by the underlying wing cells (6).

During normal exfoliation,

desquamating cells are released only after the replacement cell has established new

tight junctions with neighboring cells and the new apical membrane is capable of
maintaining continuity of the tear film (6).

Studies of induced exfoliation of a

monolayer of epithelial cells with a biologic detergent indicate recovery of the

paracellular barriers and transepithelial electric resistance in approximately 1 hour (hr)
(6). The epithelium completely turns over in approximately seven days (6). Once

injured, a high degree of motility ensures coverage of a discarded area by adjacent
basal cells, followed by replacement of the normal complement of cell layers. Basal

cells are the only epithelial cells capable of mitosis; however, many epithelial cells
originate as the progeny of limbal stem cells and migrate to supplement or replace cells
lost through normal desquamation or injury (6). Using immunohistochemical (IHC)
staining for antibodies to keratins, Wiley, et al. (2006), found regional heterogeneity
indicating that the superior corneal periphery and limbus have the greatest numbers of
stem cells producing replacement epithelial cells (6). Limbal stem cell deficiency may
result in conjunctival epithelium invasion of the cornea, leading to vascularization, the
appearance of goblet cells, and an irregular or unstable epithelium that reduces visual
acuity and may produce pain or discomfort (6).
The corneal epithelium is known to chemically interact with keratocyte cells of
the stroma.

These interactions appear to be dominated by cytokines such as

interleukin-1 (IL-1) and soluble Fas ligand that are released by injured epithelial cells

7

(6). It is presumed that IL-1 is a master regulator for corneal wound healing given its
effect on keratocyte apoptosis and the modulation of matrix metalloproteinase and

growth factors such as keratinocyte growth factor (KGF) and hepatocyte growth
factor (HGF) (6). The Fas ligand system is known to influence the immune state of
the cornea. In addition to the epithelial-to-keratocyte communication, keratocytes

influence the state of the epithelium via HGF and KGF, which affect cell turnover,
motility, and proliferation (6).

In dry eye, climate is a potential causative agent and people living in dry, arid
environments (i.e. retirees in Arizona) experience symptoms associated with the
condition. While the exact cause of these symptoms remains unclear, ocular dryness

due to increased tear evaporation may be due to low humidity, high room temperature
and air velocity, decreased blink rate, or indoor pollution or poor air quality (8). Due
to the fact that the epithelium is the outermost layer of the cornea, this cell layer is

directly exposed to the external environment and will be a particular area of interest
during this study because injury to these cells will be indicative of dryness to the ocular
surface. Corneal staining will indicate whether injury has occurred and graded using
the scoring system suggested by Viau, et.al (2008) (1). Corneal thickness will be
another area of interest because the interactions the corneal epithelium has with

keratocyte cells, growth factors, the Fas ligand system, and cytokines will indicate that
an inflammatory response due to injury is present and wound healing has occurred.
The conjunctiva is a thin, semitransparent mucous membrane that covers the
posterior surface of the eyelids and is then reflected onto the eyeball, where it extends
to the edge of the cornea (9). The conjunctiva takes its name from the fact that it
conjoins the eyelids with the eyeball (9). This junction is indirect, with the conjunctiva

forming a fornix on three sides of the globe and an extendible plica on the fourth side
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(9). The fornixes and plica of the conjunctiva are loose arching folds connecting the
conjunctival membrane lining the inside of the eyelid with the conjunctival membrane
covering the eyeball.

This arrangement allows the globe and eyelids to move

independently of each other (9).

The cellular structure and organization of the conjunctiva is nonkeratinizing

squamous epithelium containing mucin-secreting goblet cells (9).

This epithelium

overlies a loose connective tissue, the substantia propria, which is highly vascularized,

contains afferent and efferent sensory innervation and is rich with lymphoid tissue.

The conjunctiva functions to enable independent motion of the globe and eyelids but it

also protects the cornea and the interior of the eye from the external environment by
secreting mucins, antibacterial proteins, electrolytes, and water to form the inner
mucous layer of the tear film and possibly a portion a of the aqueous layer. Without
these normal conjunctival secretions, a variety of mucous-deficiency diseases develops
and can lead to extensive damage to the cornea and sight-threatening conditions (9).
The conjunctiva may be divided into three major subdivisions: the tarsal, or

palpebral, lining the eyelids, the forniceal, lining the upper and lower fornices, and the
bulbar, overlaying the sclera on the anterior portion of the globe (9). The tarsal
conjunctiva lies in a shallow groove called the subtarsal groove (9). This groove runs
parallel to the eyelid margin for most of the length of the tarsal conjunctiva. The
groove marks the area of transition from the nonkeratinized, stratified squamous
epithelium of the eyelid margin to the cuboidal epithelium of the tarsal conjunctiva.
The groove provides an ideal anatomical trap for small foreign objects before they can
reach the cornea and bulbar conjunctiva. The objects trapped in the subtarsal groove

are covered with a thick coating of mucus and are moved medially by the blink to be
carried out on, and trapped by, the hairs of the caruncle. There are multiple smaller
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ridges and grooves between the eyelid margin and the tarsal groove that contain a
series of small saccular mucus glands. Each of these glands has a tubular lumen that

opens onto the conjunctival surface. These glands are formed by an invagination of
the conjunctival epithelium and are lined with mucus-secreting epithelial cells (9).
The bulbar conjunctiva is smoother than the palpebral conjunctiva and its
surface features are less consistent. There are often four to six low broad papillae

about the corneoscleral limbus that range in size. The palisades of Vogt are structures
around the limbus that radiate outward from the cornea. One of their functions is to

trap small foreign objects that were on the cornea and were subsequently dislocated by

blinking. The palisades are often outlined by a fine brown line that radiates from the
cornea. This is caused by the production of pigment from an increase in the local
melanocyte population, which makes these structures easy to identify (9).
The basal conjunctival epithelial cells are attached by desmosomes to a

basement membrane. The tarsal conjunctiva is firmly attached to the tarsi. Meibomian

glands are visible in both the upper and lower eyelids as yellow streaks running
perpendicular to the eyelid margin.

From the fornices, the conjunctiva sweeps

posteriorly to attach to and cover the eyeball. Medially it variably covers the globe
posterior to the limbus. The conjunctiva forms four fornices where it is reflected from
the eyelids to the globe (9).

In addition to the epithelial cells, goblet cells are the second cell type found in
the conjunctival epithelium and are the main source of mucus secretion. Found singly

or in clusters, goblet cells are dispersed among the stratified squamous cells of the
conjunctival epithelium. Goblet cells contain secretory granules in the apical portion
of the cell that contain the mucins and other glycoproteins that are secreted onto the

mucus layer of the tear film. MUC5AC, the large gel-forming mucin that is the major
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mucin present at the ocular surface, has been identified to be associated with the

goblet cells, but other mucins, such as MUC2 and MUC7, may also be associated (9).
The main lacrimal gland is located in the superotemporal orbit in a shallow
lacrimal fossa of the frontal bone and it is surrounded by fibrous tissue that is attached

superiorly to the frontal bone periosteum (10). It is incompletely divided into a larger
orbital lobe, which comprises 60% to 70% of its total mass, and a smaller palpebral
lobe below. Blood vessels, nerves, and the lacrimal ducts connect the two lobes (10).

The lacrimal gland is divided into numerous lobules, separated by interlobular
fibrovascular connective tissue. Each lobule is structurally composed of the acinar unit

and the ductal system (9). Two to six secretory ducts from the orbital lobe of the
lacrimal gland pass through the palpebral lobe or along its fibrous capsule, joining with
ducts from the palpebral lobe to form six to twelve tubules that empty into the
superolateral conjunctival fornix above the tarsus (10).

The ducts, lined by

pseudostratified, nonkeratinizing squamous epithelium, form a branching pattern
within the lacrimal gland. Secretion from the acinar units first drains into the smaller
intralobular ducts, proceeds through the larger interlobular ducts, and eventually
passes into the main excretory ducts before draining into the superolateral conjunctival
fornix (9). The surface of the ductal lumina contains microvilli, similar to the acinar
secretory cells. The epithelial walls of the larger ducts contain three to four layers of

columnar or cuboidal cells, compared with a single layer in the smaller intralobular
ducts (9).

Each acinar unit, or secretory unit, of the lacrimal gland is composed of an
inner layer of columnar or pyramid-shaped secretory cells around a central lumen, and
a surrounding basal layer of myoepithelial cells (10). The nucleus is located at the

base of the acinar secretory cell, and numerous membrane-bound zymogenic secretory
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granules are present in the apical cytoplasm (10). The number and size of granules,
which contain predominantly serous proteins for secretion, vary from cell to cell.
Typically, larger granules are located in the peripheral lobules (10). The zymogenic
secretory granules fuse with the apical cell membrane and release their granular
contents into the acinar lumen through exocytosis (10).

Myoepithelial cells are

spindle- or basket-shaped cells, composed of cytoplasmic myofilaments, located
between the base of the secretory cell and the basement membrane of the acinar unit

(10). Contraction of the myoepithelial cells helps drive secretions into the drainage
tubules and ducts (10).

Accessory lacrimal glands are located in the conjunctival fornices and along the
superior tarsal border (10). There are approximately twenty to forty accessory glands

in the superior conjunctival fornix (10). There is approximately half the number of
glands present in the lower eyelid as in the upper eyelid (10). Slightly larger accessory

glands are located along the superior tarsal border in the upper eyelid and in the lower
eyelid (10). The accessory lacrimal gland lobules empty onto the conjunctival surface
through small branching ducts that drain into a single excretory duct that is lined by
one or two layers of cells (10).

The accessory lacrimal glands are innervated like the main lacrimal gland (10).
Parasympathetic, sympathetic, and sensory nerves have been identified in accessory

lacrimal glands of human tissue (10). The presence of nerves suggests that secretion
from accessory lacrimal glands is regulated by the nervous system, which suggests that
the accessory lacrimal glands can also contribute to stimulated tear secretion (10).

The lacrimal gland secretes water, electrolytes, and proteins in response to

neural and hormonal stimulation and is the major contributor to the aqueous portion of
the tear film with additional contributions from the accessory lacrimal glands, the
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cornea, and the conjunctiva (10). Parasympathetic nerves, containing acetylcholine
(ACh) and vasoactive intestinal peptide (VIP), and sympathetic nerves containing
norepinephrine (NE), provide strong stimuli of lacrimal gland secretion (10).

In

addition, many hormones from the hypothalamic-pituitary-gonadal axis have
significant influences on the lacrimal gland, including stimulating secretion of secretory
immunoglobulin A (SIgA) (10). Sensory nerves are the least prevalent and release
substance P and calcitonin gene-related peptide. In the lacrimal gland, each of these
agonists binds to specific receptors on the acinar cells and initiates a different cascade
of cell signaling transduction pathways (10).
Tear film secretion from the lacrimal functional unit is reflexive (12).

The

sensory nerves of the highly innervated cornea and conjunctiva form the afferent limb
of a simple reflex arc that conducts stimuli from the external environment back to the
central nervous system (12). The efferent limb of the reflex arc is composed of the
sympathetic and parasympathetic nerves that innervate the ocular surface epithelia and
tear-producing glands (12).

These nerves are responsible for stimulating the

conjunctival epithelial goblet cells, lacrimal glands, and meibomian glands to secrete
their respective components (mucus, aqueous, and lipid, respectively) onto the ocular

surface to provide protection from the original stimulus (12).
The tear film is responsible for providing a smooth refractive surface for clear

vision, maintaining the health of corneal and conjunctival epithelia, and acting as the
first line of defense against microbial infections (12).

Tear film composition is

dynamic and in a constant state of flux, responding to environmental conditions in
order to maintain ocular surface homeostasis.

Traditionally, the tear film was

described as being composed of three separate and distinct layers: mucin, aqueous, and
lipid (12). However, new studies suggest that mixing between the mucin and aqueous
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layer occurs which creates a gradient of decreasing mucin concentration into the

aqueous layer (12). This aqueous-mucin layer forms a complex, hydrated gel, which is
then covered by the lipid layer, which has its own highly ordered structure (12).
The majority of ocular mucins are secreted by the conjunctival goblet cells
(12).

Ocular mucus is composed of mucin, immunoglobulins, urea, salts, glucose,

leukocytes, cellular debris, and enzymes (12).

Mucins are high molecular weight

glycoproteins that are heavily glycosylated where 50% to 80% of their mass can be
attributed to their carbohydrate side chains (12). Tandem repeats of amino acids rich
in serine and threonine found in their protein backbone serve as sites for O-type
glycosylation (12). Heavy glycosylation contributes an overall negative charge to the

glycoprotein, making the mucins highly hydrophilic and able to mix with the aqueous
layer and maintain water on the surface of the eye (12).
Mucins are classified as either membrane-associated or secretory. Secretory

mucins are further divided into two groups: large gel-forming mucins or small soluble
mucins (12). Secretory mucins act as a "cleaning crew," moving through the tear fluid
and collecting debris that can then be removed via the nasolacrimal duct during
blinking (12).
Large membrane-associated mucins form the glycocalyx, a dense barrier to
inhibit pathogen infiltration, at the epithelial cell-tear film border (11).

Secreted

mucins move easily over the mucins composing the glycocalyx because of the
repulsive forces between them, which result from their anionic character (12). The
membrane-associated mucins contain a hydrophobic transmembrane domain that
anchors the mucin on the apical surface of the epithelial cells, a short cytoplasmic tail
that extends into the cytoplasm, and an extracellular domain that reaches into the tear

film (12). The extracellular, highly glycosylated tandem repeat domains, also called
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ectodomains, function to prevent adhesion via cell-cell and cell-matrix interactions
(12). This property provides a lubricating surface that allows eyelid epithelia to glide
over the corneal and conjunctival epithelia without adherence (12). The cytoplasmic
tail of the membrane-associated mucin is thought to affect epithelial activity by

interacting with cytoplasmic proteins and facilitating signal transduction (12).

The

short cytoplasmic domains are also reported to be associated with the actin
cytoskeleton, which helps support the microplicae structure (12).
Soluble forms of the membrane-associated mucins have also been identified in

the tear film, although the exact mechanisms for this occurrence are still unknown

(12). Possible mechanisms include: cleavage and release of the extracellular domain

into the tear film in a process termed ectodomain shedding, posttranslational
processing of the mucin into two subunits where one subunit remains anchored in the

plasma membrane and the other soluble subunit is packaged in secretory granules and
released into the tear film, or mucin shedding from the cell surface over time leaves the
oldest cells without microplicae and membrane associated mucins, which results in the
adherence of the old cells to the mucus of the tear film and their removal via the

nasolacrimal duct (12).

The middle aqueous layer of the tear film consists of water, electrolytes,
proteins, peptide growth factors, immunoglobulins, cytokines, vitamins, antimicrobials,
and hormones secreted by the lacrimal glands (12).

Electrolytes present in the tear film include sodium, potassium, magnesium,

calcium, chloride, bicarbonate, and phosphate ions. These electrolytes are responsible

for the osmolarity of tears, acting as a buffer to maintain a constant pH and contribute
to maintaining epithelial integrity of the ocular surface. An increase in osmolarity of
the aqueous layer is a global feature of dry eye syndrome and damages the ocular
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surface directly and indirectly by triggering inflammation (12).

More than sixty proteins have been identified in human tears including albumin,
immunoglobulins,

metal-carrying

proteins,

histamine,

prostaglandins, proteases, and antimicrobials (12).

plasminogen

activator,

Considering that the thin,

nonkeratinzed epithelium and abundant blood supply of the conjunctiva make the
conjunctiva an ideal entrance for infectious agents, it is imperative that the ocular
surface has a strong defense system to protect against invading microorganisms (12).

The primary defense system of the ocular surface is composed of the nonspecific
immunity presented by lysozyme, lactoferrin, p-lysin, defensins, and group II
phospholipase A and the specific immunity of antibodies (12). Immunoglobulins are
constitutively produced and transported to the tear film from the conjunctiva. Thus,

reflex tearing reduces the concentration of immunoglobulins and a reduction in tear
flow increases their concentration (12). In aqueous-deficient dry eye syndrome, the

concentration of lysozyme, lactoferrin, lipocalin, and SIgA are reduced, compromising
the integrity of the defense system, which may make the ocular surface more
susceptible to infection, in addition to the symptoms of dry eye (12).

The anterior layer of the tear film is composed of meibomian oil secreted by

the meibomian glands and is the major barrier to evaporation from the ocular surface
(12). The lipid layer is also responsible for providing stability to the tear film through

interaction with the aqueous-mucin phase, providing a smooth optical surface for the
cornea, and acting as a barrier against foreign particles (12).

Oil secretion is a

continuous process, occurring twenty-four hours per day during waking and sleeping
hours, and is aided by blink action. The rate of secretion is controlled by neural,
hormonal, and vascular influences (12). A normal tear film lipid layer is able to reduce

evaporation by approximately 90% to 95% (12). The rate of evaporation is affected
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by the thickness of the lipid layer, and it has been proposed that a decrease in thickness

may cause evaporative dry eye (12). Mild to moderate dry eye states exhibit a lack of
confluence in the tear film lipid layer (12).

The conjunctiva, lacrimal functional unit, and tear film all work together to

maintain the integrity of the ocular surface and provide a moisture-rich environment.
If any of these components is compromised, the eye may become susceptible to
infection and disease. In the case of dry eye, evaporation of the tear film may be
caused be environmental factors such as a dry, arid climate or dysfunction of the
lacrimal unit. Evaporation may also be caused by the lack of lipids protecting the
aqueous layer of the tear film due to dysfunction of the meibomian gland.

This

dryness causes discomfort and pain therefore decreasing quality of life. Understanding

how these cells and tissues function together is crucial to discovering the cause of dry
eye but in order to determine if a patient has dry eye, the proper diagnostic measures

must be made and the efficacy of available drugs must also be evaluated. The dry eye
model used in this study intends to provide this information.
Classification ofDry Eye Animal Models
Lacrimal Inflammation

A number of animal models of dry eye have been developed including rabbit,
mouse, rat, canine, feline, and primate. Several animal models studying lacrimal

inflammation have been developed, with particular attention to the early activation and
infiltration of autoreactive lymphocytes (3). The nonobese diabetic (NOD) mouse

model shows a lymphocytic infiltration of predominantly CD4+ Thl cells in the

lacrimal gland (13). Male NOD mice show significant inflammatory lesions of the
lacrimal gland from the age of eight weeks, whereas female NOD mice do not show
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any changes until thirty weeks of age. Although significant attention has focused on
lacrimal lesions in NOD mice, the only published study demonstrating altered tear
secretion in these mice reported a reduction by 33 - 36% compared with wild-type
animals; a reduction rate that is less profound than the decreased lacrimal function in
patients exhibiting lacrimal inflammation (14). The consequences of the reduced tear

production of the ocular surface epithelium of these mice have never been definitively
demonstrated and suggest this model is better fitted for studying secondary but not
primary lacrimal inflammation (13).

The MRL/MpJ-fas+/fas+ (MRL/+) and MKL/MpJ-faslpr/faslpr (MRL/lpr) mouse
models of lacrimal inflammatory syndrome exhibit lacrimal gland infiltrates

characterized by a predominance of CD4+ T cells (15). In contrast to the NOD model,
the extent of the lacrimal gland inflammation is significantly greater in lacrimal glands
of female MRL/+ and MRL/lpr mice than is observed in males, resembling the

difference observed in human lacrimal inflammatory syndrome (16). In the MRL/lpr
mouse, the lacrimal gland inflammation has an earlier onset (1 month of age) and a

greater severity at same ages as in the MRL/+ mice (onset at 3 months), indicating that
the Ipr flymphoproliferation) mutation accelerates, rather than causes the disease. The

defective lymphocyte apoptosis (thought to regulate T cells reactivity naturally) in
MRL/lpr mice due to an Ipr mutation in a single autosomal recessive gene controlling

the Fas antigen occurs systemically and outside the lacrimal gland, and therefore is not
itself due to the micro-environment of the lacrimal gland in this mouse model.
According to Toda, et ah (1999), the Ipr gene itself does not cause severe

immunopathologic lesions in the lacrimal tissue, since male C3H/lpr and gld

(generalized lymphoproliferative disease) mice show almost no lymphocyte
accumulation in the lacrimal gland (16).

These findings seem to support the
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hypothesis that Fas antigen and Fas ligand are not critical gender- and strainindependent

determinants

of autoimmunity

in

lacrimal

tissue

(17).

The

immunopathology of this model is unique, in that the predominance of IL-4 and B7-2

within the lacrimal gland lesions of MRL/lpr mice suggests a largely Th2-type
response, distinct from that in the NOD model (18). Overall, these data suggest the

existence of potentially divergent immunopathogenic mechanisms to lacrimal
autoimmunity in the mouse (3).

Autoimmune phenomena in Fl hybrids of New Zealand Black and New
Zealand White (NZB/NZW Fl) mice are comparable to MRL/lpr mice and are
similarly more severe in females than in males, but lesions in the lacrimal glands of the
Fl mice become evident after only 4 months instead of 1 month (18). The effect of

lacrimal inflammation on the ocular surface of these mice is poorly described. In fact,
Gilbard, et. al (1987), demonstrated the lack of corneal epithelium abnormalities in
NZB/NZW Fl mice along with a normal tear film osmolarity, despite the lacrimal

gland infiltration, emphasizing the important point that lacrimal and ocular surface
disease do not necessarily correlate (19).
There are several other other murine models that are also associated with a

predominant CD4+ T lymphocyte infiltration of the lacrimal gland (3). The TGF- (31
knockout mouse, for example, has shown significant inflammatory cell infiltrates in the

lacrimal gland between the ages of 2 and 4 weeks, whereas the globe itself exhibits a
normal structure and phenotype upon histologic examination (20). Unfortunately,

shortly after weaning, the mice begin to show the symptoms of a wasting syndrome
and die between three and four weeks. Providing liquid diet supplements at the time

of weaning prolongs survival of TGF-B1 knockout mouse almost twice as long as
providing standard hard diet, thus enabling longer observation of these mice (21). The
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shortened life of the TGF- pi knockout mouse generally complicates their use as a
model, particularlyfor studies involving testing of therapeutics (3).

Mice homozygous for an autosomal recessive mutation, alymphoplasia (aly),
which causes a systemic absence of lymph nodes and Peyer's patches, have also been
demonstrated to have infiltration of CD4+ T cells into their lacrimal and salivary

glands, lung, liver, kidney, and pancreas, potentially serving as a model of lacrimal
inflammatory syndrome (22). In particular, lymphocytic infiltrates can be detected in
the lacrimal gland from the age of 14 weeks in both males and females.

Several

factors complicate the use of these mice for study of ocular surface disease. First, no
definitive data have been produced relating the lacrimal gland infiltration to altered
tear secretion in these mice. Second, the absence of lymph nodes, together with a

variety of other serious immune defects, including depressed baseline immunoglobulin
production and isotype switching, defective T cell function, and faulty homing
responses, all confound the study of the effect of lacrimal insufficiency on the eye, as
each of these factors alone or in combination may affect the cornea and ocular surface
(3).

The IQI/Jic has recently been established as a new mouse model for primary
lacrimal inflammatory syndrome. Unlike the NOD model, in the IQI/Jic mouse the
lymphocytic infiltration is well restricted to salivary and lacrimal glands (3). Konno,
et. al. (2003), have suggested that in this model, the early phase of adenitis (lacrimal
inflammation) is mediated by dendritic cells that promote induction of Thl-type
immunity, which may also be potentiated by lacrimal epithelial cells that also function
as secondary antigen-presenting cells (APCs) (23).

The general phenotype of this

mouse model of lacrimal inflammatory syndrome makes it quite attractive for the study
of the early phases of the disease, even if the development of complete dacryoadenitis
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(lacrimal inflammation) at an advanced age (9 months) makes it economically

unappealing.

Another model for inducing salivary and lacrimal gland specific

lymphocytic infiltration, but at a more rapid pace, has been developed by injecting
mononuclear cells isolated from the inflamed submandibular salivary tissues of

MRL/lpr mice intraperitoneally into Scid mice (3). At 8 weeks after the injection,
these Scid mice exhibit inflammatory lesions in the salivary and lacrimal glands, but not

in other organs, confirming the tissue-specificity of disease in these animals. Of
interest, the injection of lymphocytes from the spleen of the MRL/lpr mice have not
produced any inflammatory lesions in Scid mice (24).

Human lacrimal inflammatory syndrome is characterized by the presence of
serum autoantibodies to the ribonucleoprotein particles SS-A (anti-SS-A/Ro, 52 kDa;
anti-SS-A/Ro, 60 kDa) and SS-B (anti-SS-B/La) (25), and, as recently demonstrated,
anti-120-kDa a-fodrin (26), and anti-M3 and -Ml muscarinic acetylcholine receptors

(27). Autoantibodies are also present in the serum of NOD and MRL/lpr mice, but
with a different pattern of expression than what is observed in humans (3). The role of
autoantibodies in NOD mouse has been postulated based on the observation that NOD

Igunu11 mice (lacking B lymphocytes) maintain normal secretory function, even in the
presence of focal infiltrates in the salivary gland, suggesting that humoral immunity
plays a critical role in the pathogenesis of autoimmunity in these animals (28).
Furthermore, the infusion of anti-M3 muscarinic receptor antibodies into NOD-Scid
mice produces a decreased salivary response (29).

To date, there have been no

published data about the influence of anti-M3 muscarinic receptor antibodies on tear
production (3).

Finally, NFS/sld mice thymectomized at 3 days of age (3d-Tx NFS/sld) have
also been used as a model of primary lacrimal inflammatory syndrome to identify the
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autoantigen 120-kDa a-fodrin (26). In particular, this autoantigen, purified from the
salivary glands of 3d-Tx NFS/sld mice, postulated as the presenting antigen in salivary

gland disease in lacrimal inflammation, has been demonstrated to be the product of
caspase 3 cleavage of the 240-kDa a-fodrin, rendering this model ideal for study of the
mechanism of apoptosis in lacrimal inflammatory syndrome. However, the profound

effect of the thymectomy on the endocrine-immune system limits the use of this model
for long-term prospective studies (3).

Rabbits have a much larger ocular surface compared to mice which makes
performing studies on these animals much easier. Zhu, et. ah (2003), induced an
autoimmune disease in rabbits resembling lacrimal inflammatory syndrome by injecting
into the lacrimal gland autologous peripheral blood lymphocytes proliferated in culture

with epithelial cells obtained from the contralateral excised gland (30).

The

histopathologic picture of the lacrimal glands so treated was similar to the findings in

patients with lacrimal inflammartory syndrome, with predominantly CD4+ T cell
infiltrates (30). A continuous decrease in tear production and stability and an increase

in rose bengal staining of the ocular surface, were recorded in eyes injected with
activated lymphocytes and in the contralateral lacrimal gland-excised eyes by 2 weeks,
indicating a generalized autoimmune phenomenon (30). An important lingering point
to verify in this model is whether the acinar cell preparation (the putative APCs of this
model) is completely devoid of any professional bone marrow-derived APCs that can
stimulate the T cells (3).
Experimental immune dacryoadenitis has been produced in Lewis rats by
sensitization with a single intradermal administration of an extract of lacrimal gland in
complete Freund's adjuvant (CFA) and simultaneous intravenous injection of killed

Bordetella pertussis (31).

No data have been published about the effect of this

22

procedure on the ocular surface (3).

Mechanical Control of Lacrimal Secretion

In dogs, cats, rabbits, and mice the removal of the main lacrimal gland

produces a decrease in basal tear production as measured by the Schirmer test, but it
does not cause significant changes in ocular surface signs, even after a long follow-up

(3). This may be due to accessory lacrimal glands that could provide an adequate

compensatory tear supply. In rabbits, closing the lacrimal gland excretory duct and
surgically removing the nictitating membrane and harderian gland can cause an
increase in tear osmolarity at postoperative day 1 accompanied with significant
decrease in conjunctival goblet cell density by 8 weeks (3).

Monkeys have one main lacrimal gland with an anatomic structure similar to
that in humans. The removal of the lacrimal gland has been demonstrated to decrease

tear secretion, but without producing any reproducible ocular surface damage (32).
As in other species, it is thought that compensatory tear production by the accessory
lacrimal glands alone may be sufficient enough to maintain a stable tear film (3).

Endocrine Control of Lacrimal Secretion

Spontaneous development of dry eye due to specific endocrine imbalance has
not been shown in any animal models to date.

Nevertheless, orchiectomy and

ovariectomy in rabbits, rats, mice, guinea pigs, and hamsters, and hypophysectomy in
rats, have been used as models to study the influence of hormones on the structure and
function of the lacrimal and meibomian glands (3). These procedures are not meant as

an exact mimic of dry eye, but to decipher important pathogenic aspects of tear film
regulation (3). Hormones have both direct and indirect effects on exocrine tissues due
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to their capacity to regulate immunity as well as the gene expression of many secreted
molecules. For example, Sullivan, et. al. (2002), have demonstrated that androgens

regulate the function of lacrimal glands and the quantity, quality, and metabolism of
the lipid layer of the tear film produced by the meibomian glands (33). This may be an
indication why women in the U.S. over the age of 50 display increased signs of dry eye
because they have gone through menopause which causes a change in estrogen levels.

Genetically modified mice are expected to aid in the study of the influence of a specific
hormone(s) on the tear film homeostasis (3).

Neuronal Control of Lacrimal Secretion

The ocular surface (cornea, conjunctiva, and accessory lacrimal glands),

meibomian glands, and main lacrimal gland, are interconnected by neural reflex loops
that maintain an integrated "functional unit" (34). The only dry eye animal model
described in the literature that supposedly mimics a blockade of the neural reflex loops

involved in maintaining the normal tear physiology has been created by administrating
the anticholinergic agent atropine in New Zealand albino rabbits (3).

The

antimuscarinic effect of topical 1% atropine sulfate has been shown to reduce lacrimal

secretion significantly within 2 days and to induce corneal epithelial defects by 3 days
(35). Intramuscular doses of atropine are not recommended for use, because they
produce toxic systemic side effects and fail to induce corneal damage (3).
The MLR/lpr mouse model has been used to test the hypothesis that a

reduction of the quantity of parasympathetic fibers, or an alteration in the
neurotransmitters in the healthy tissue of the lacrimal gland, is responsible for tear
decrease in patients with lacrimal inflammatory syndrome (3). Zoukhri, et. al (1998),
have shown, however, that in the MRL/lpr model, parasympathetic, sympathetic, and
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sensory innervations of the lacrimal gland are not altered and the Ca2+ signaling
portion of cholinergic nerve transmission is indeed up regulated with the onset of
lymphocytic infiltration in these mice, suggesting that inadequate innervation of
exocrine tissue alone cannot explain the partial deficit in lacrimal secretion (36).
Evaporative Dry Eye

The ocular surface is constantly exposed to multiple environmental factors

which may lead to evaporation, including low humidity, high room temperature and air
velocity, decreased blink rate, or indoor pollution or poor air quality (10). The lipids
produced by the meibomian glands and spread onto the aqueous phase by the shear

forces produced by each blink, protect the tear film from excessive evaporation (3).
Short-term models for hyperevaporative dry eye have been created by preventing
rabbits from blinking through placement of lid specula or sutures (3). After two hours

of desiccation induced by lid specula, dry spots appear on the rabbit corneal epithelial
surface and stain with methylene blue (37). Because of the acuteness of the induced
dry eye and the use of anesthetics (which themselves can decrease tear secretion),
these models are not optimal for studying KCS pathogenesis, which is a chronic event.
However, in these rabbits, corneal epitheliopathy develops within a few hours, and
hence such rabbits can be used to evaluate the effect of artificial tears or other

therapies aimed at delaying the evaporative loss of the tear film (3).

Histopathologic and clinical studies indicate that meibomian gland duct orifice
closure is a characteristic feature of meibomitis-related dry eye (3). The first objective

evidence in support of this hypothesis was provided by Gilbard, et. al. (1989) who
used a rabbit model in which the meibomian gland orifices were individually closed by
cauterization (38). They demonstrated not only a significant decrease in conjunctival
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goblet cell density and corneal epithelial glycogen levels by twelve weeks, but also the
presence of inflammatory cells within the bulbar conjunctiva after twenty weeks (38).

Although this model is an interesting one for studying the effect of meibomian gland
dysfunction on the ocular surface, this is best done in a controlled environment in
which temperature, humidity, and airflow are constantly monitored and controlled (3).
This would more closely reflect the clinical setting, where it has been demonstrated

that the tear film evaporation rate from the ocular surface is temperature-, humidity-,
and airflow-dependent (39). Recently, several novel mouse models of meibomian

gland dysfunction have been created. These models provide new insights into the
pathophysiologic mechanisms of hyperevaporative dry eye and identify potential novel
gene therapy targets (3).
Combined Lacrimal Insufficiency and Evaporative Dry Eye Models

Dursun, et. al. (2002), have presented a mouse model of KCS in which
transdermal scopolamine application and exposure to a continuous airflow are used to

induce dry eye in female mice (40).

The function of scopolamine is to induce a

pharmacologic blockade of cholinergic (muscarinic) receptors in the lacrimal gland and
therefore to decrease aqueous production, whereas the airflow is to mimic
environmental stressing conditions (with resultant increased evaporation) (40).

Alterations to aqueous tear production and volume, tear clearance, corneal barrier
function, conjunctival morphology and goblet cells density, resemble those of human
KCS. However, the tear production has been shown to be reduced only in the group
of mice treated with scopolamine, whereas the airflow does not appear to influence the

tear film and ocular surface signs (3).

Although there are significant benefits to

studying sicca-related ocular surface disease in mice that do not have concomitant
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systemic immune dysfunction, this model has yet to be optimized, as it does not
adequately control important environmental factors such as temperature and

humidity—important factors that can have profound effects on the exposed ocular
surface (3). Moreover, the airflow generated by an air fan placed six inches in front of

the mice's cage for ten hours a day for twelve consecutive days may be a source of
stress for mice and therefore influence the data on the tear film homeostasis. This may

be a model that best represents the neural inhibition of tear secretion through

pharmacologic inhibition of cholinergic pathways more than a "pure" hyperevaporative
dry eye model (3).
Spontaneous KCS

In 1979, Quimby first recognized the similarities between the dogs with severe

KCS, xerostomia, vaginal dryness, and multiple serum antibodies and lacrimal
inflammatory syndrome in humans (3). This likeness has been confirmed lately by a
study of lacrimal glands and conjunctiva in KCS dogs by TUNEL (Terminal
deoxynucleotidyl transferase dUTP nick end labeling) assay, revealing a decrease in

apoptosis in the lymphocytes infiltrating the lacrimal gland and an increasein apoptosis
in lacrimal acinar and conjunctival epithelial cells (41). The spontaneous canine dry

eye model has been widely used to develop therapeutic interventions for both
veterinary and clinical populations, as exemplified by trials on topical application of
cyclosporin A (42).

The incidence of KCS in the general canine population is

unknown, although in one study of 460 dogs, the prevalence was estimated at 35%,
with particular predisposition among aged dogs of either sex (42). The breed with the
highest relative prevalence of KCS is the American cocker spaniel (20.6%), whereas
the commonly used laboratory dogs such as mixed-breed and beagle dogs have lower
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prevalence rates of 11.5% and 1.2%, respectively (42). Even if there are multiple
causes of canine KCS (i.e. distemper virus, drug-induced), most are of undetermined

origin and may be immune mediated.

Spontaneous KCS in dogs provides a very

useful model for dry eye studies: the large size of the dog's globe compared with that
of the mouse provides benefits for ocular surface diagnostic tests, as well as collection

and study of tears and mucin, which is difficult to perform in small rodents (3).

Negative aspects of this model include the outbred source of most dogs, their
maintenance costs, and potential difficulties with receipt of animal care and use
committee approval for experimental procedures on this species (3). Finally, it must

also be emphasized that signs of dry eye tend to be considerably more severe in dogs
than in humans. Hypertrophic and hyperemic conjunctiva, mucous filaments, and a

thick persistent mucopurulent ocular discharge, corneal vascularization, corneal
melanosis, and reoccurring ulcers, are not infrequent in canine dry eye (3).

The existing animal models of dry eye mimic different pathogenic mechanisms
of KCS, but at the moment none of them seems to mirror precisely the complexity and

chronicity of this frequent and debilitating condition (3). Despite their small size, the
advanced murine immunogenetics and extensive availability of reagents and knockout

and transgenic strains make the mouse a very attractive model.
incorporating

both

intrinsic

(immune,

endocrine,

Further studies

neuronal) and

extrinsic

(environmental) factors in dry eye pathogenesis in the mouse will offer important
advances in the field (3).
New Scopolamine-Induced Dry Eye Model in Rats

Dry eye was induced in six week old female Lewis rats by a systemic and
continuous delivery of scopolamine via osmotic pumps implanted subcutaneously.

28

Daily scopolamine doses of 12.5 mg and 25 mg applied for a 28-day period induced
keratitis, a decrease in Muc5AC immunostaining density in the conjunctival epithelium,
and modifications in the fatty acid composition of the exorbital lacrimal gland.

Animals treated with a 12.5-mg/day dose of scopolamine exhibited an increase in
corneal fluorescein staining after 2, 10, and 28 days. All animals exhibited unilateral or
bilateral keratitis after 17 days. In the conjunctival epithelium, a significant decrease in
Muc5AC immunostaining density was observed at early and late time points, and

MHC II expression tended to be increased after 1, 7, 10, and 28 days, without
reaching statistical significance. The levels of TNF-a, IL-ip and IL-6 mRNA were

increased with scopolamine treatment in both conjunctiva and exorbital LG. This
systemic and continuous scopolamine-induced model of dry eye in the rat may
represent a helpful tool to investigate moderate dry eye (1).
Selected Dry Eye Model

The scopolamine-induced dry eye model was selected for this study due to the
effectiveness of scopolamine in mimicking the symptoms of dry eye and the methods
that were used to evaluate clinical signs of dry eye. Scopolamine was used as the
induction article and its function is to induce a pharmacologic blockade of cholinergic
(muscarinic) receptors in the lacrimal gland and therefore to decrease aqueous
production (3). It has been demonstrated that scopolamine has a high selectivity for
the muscarinic receptor, although it has been reported that high doses of scopolamine
will also block nicotinic receptors. Since scopolamine has no preference for one of the
different muscarinic subtypes, scopolamine will block the effects of acetylcholine at the

muscarinic receptor throughout the body and brain and affect various physiological
functions (43).

Scopolamine was administered systemically via an Alzet® osmotic
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pump (Model 2ML4) implanted subcutaneously for 28 days at 12.5 mg/day. The

osmotic pump was used for a number of reasons. Mainly because it is small enough to
use in rats and allows for targeted delivery of test article to virtually any tissue. It
ensures around-the-clock exposure to test agents at predictable levels as well as

provides a convenient method for the chronic dosing of laboratory animals.

It

minimizes unwanted experimental variables and ensures reproducible, consistent
results. It also eliminates the need for nighttime or weekend dosing which in turn
reduces handling and stress to laboratory animals. An added bonus is that it is a costeffective research tool (44).

For Phase I, one treatment group of 5 female rats was administered

scopolamine at a dose level of 12.5 mg/day. One group of 5 animals served as a
control and was administered saline. One additional group of 3 animals served as a
control and was not administered the scopolamine nor saline. Scopolamine and saline

were administered continuously over 28 days via a subcutaneously implanted Alzet®
osmotic pump at a dose level of 12.5 mg/day. Ocular assessments, including tear
volume, fluorescein corneal staining, and corneal thickness measurements by ocular

coherence tomography (OCT), were conducted on Days 0, 2, 7, 14, 21, and 28 (see
Table 1).
Group

Number

Scopolamine Induction
(Osmotic Pumps
Implanted on Day 0)

1

5

2

5

3

5

No pump implantations

Dose;

Ocular

Duration

Assessments

Not

Days 0, 2, 7,
14, 21 and 28

Applicable

Pumps implanted/saline

Not

Days 0, 2, 7,

delivered

Applicable

14, 21 and 28

Pumps
implanted/scopolamine
delivered

12.5

mg/day;28
Days

Days 0, 2, 7,
14, 21 and 28

Termination

Day 28
Day 28
Day 28

Table 1

Phase I: Establishment

For Phase II, four treatment groups of 5 female rats each were administered
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scopolamine at a dose level of 12.5 mg/day. One additional group of 3 animals served
as the control and was not administered scopolamine. Scopolamine was administered

continuously over 28 days via a subcutaneously implanted Alzet® osmotic pump at a
dose level of 12.5 mg/day. The vehicle control, saline eye drops, and positive control

articles, Restasis® and Fluormetholone, were administered to three of the four induced
groups beginning on Day 0.

The vehicle and positive control articles were

administered topically into both eyes at a dose volume of 50 uL per eye two times
daily for 28 days. One of the induced groups served as the control and was not
administered the vehicle nor positive control articles. Ocular assessments, including
tear volume, fluorescein corneal staining, and corneal thickness measurements by
OCT, were conducted on Days -2, 2, 7, 14, 21, and 28 (see Table 2).

Group

Number

5

5

Scopolamine

Dose;

Induction

Duration

No pumps
Implanted

Applicab

Treatment

Not

5

Yes

5

Yes

5

Yes

mg/day;
28 days

No

mg/day;
28 days

5

Yes

Applicabl
e

Saline eye
drops

Restasis

mg/day;
28 days

Topical
ocular;

Pretest and

Twice

Days 2, 7,14,

daily
Topical

21, and 28

ocular,
Twice

daily
Topical

12.5

9

Applicabl
Not

mg/day;
28 days

12.5

8

Termination

e

le

12.5

7

Ocular
Assessments

Not

No

12.5

6

Route;
Schedule

FML

Table 2

Phase II: Validation

ocular;
Twice

daily

Day 28
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The main objective of this study is to understand the unique characteristics of

dry eye and its limitations to help provide further insight into the development of more
effective therapeutic solutions (3). This study will establish the dry eye condition,
identify symptoms of dry eye using ocular imaging, and confirm that healing can be
seen after application of topical medications available to treat dry eye. Previous
studies have indicated that scopolamine is an effective way of inducing the dry eye

condition by blocking muscarinic receptors that innervate the lacrimal functional unit
and interrupting the physiological processes that maintain the tear film at the ocular
surface (3).

This study also builds upon that research by eliminating variables

introduced by genetically engineered and knockout strains of rats as well as tests the
efficacy of available drugs, such as Restasis, to treat the condition. The results of this
study will provide proven diagnostic procedures to identify clinical dry eye, which
topical therapies are most effective in treating the condition, and make a contribution
in the field of dry eye study.
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MATERIALS AND METHODS

Facilities

All research for these studies were conducted at MPI Research in Mattawan,
MI.

Animals

All research conducted for these studies were compliant with all applicable

regulations governing the care and use of laboratory animals. Animal welfare for this
study was in compliance with the United States Department of Agriculture's (USDA)
Animal Welfare Act (Title 9 Code of Federal Regulations [CFR] Parts 1,2, and 3).
The Guide for the Care and Use of Laboratory Animals, Institute of Laboratory

Animal Resources, National Academy Press, Washington, DC, 1996, were followed.
The facility maintains an Animal Welfare Assurance statement with National Institutes
of Health, Office of Laboratory Animal Welfare. The study protocol and all necessary

amendments were reviewed and approved by the Institutional Animal Care and Usage
Committee (IACUC) before animal receipt or transfer.

Approximately six-week-old female Lewis rats (Charles River Laboratories)
weighing at least 150 grams were used for each phase of this study. Female rats were
used because dry eye is a condition predominantly seen in women and at around six
weeks is when a rat reaches sexual maturity (1). Rats of this age were also used
because the study that this is modeled after by Viau. et. al. (2008), used six-week-old
rats. Animals were housed in animal quarters under controlled temperature (22±1°C),

light conditions (12-hour light/12-hour dark cycle), and humidity (55-60%), with

33

water and food available ad libitum.

Filling of Osmotic Pumps

Induction of dry eye was accomplished by cholinergic blockade using
scopolamine which was continuously and systemically administered to the animals via
Alzet® osmotic pumps (Model 2ML4) for 28 days.

The induction article,

scopolamine hydrobromide, was solubilized at MPI Research by sonication and
heating to approximately 35°C. Scopolamine has been used in previous experiments

and proven to induce moderate dry eye in rats (1,2). Prior to surgical implantation of
the osmotic pumps, the induction article needed to be placed into the pumps via a
filling tube or syringe. All filling of pumps were conducted in a sterile environment via
a laminar flow hood (Labconco Purifier Class II Biosafety Cabinet). Each pump was

weighed empty (Mettler Toledo ML Model Analytical Balance) in a sterile, metal petri
dish and the value was recorded (data not shown). The flow moderator was removed

before filling.

Using a three milliliter (mL) syringe, the test article or vehicle was

drawn up and attached to a blunt-tipped 25-gauage filling tube. The osmotic pump
was held upright and the filling tube was inserted through the opening at the top of the
pump until it could go no further. The plunger of the syringe was slowly pushed until
the test material appeared in the opening and then filling stopped. The filling tube was

removed, the overflow fluid was wiped off, the flow moderator was repositioned in the
pump, and the filled pump was weighed. An empty weight was recorded because in
order for the pump to work effectively, the fill volume should be over 90% of the total

fill volume for each pump. The volume and pump delivery rate differ among lots.
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Implantation of Osmotic Pumps

Prior to subcutaneous surgical implantation of osmotic pumps, the animals

were placed in anesthesia chambers connected to isoflurane (Abbott IsoFlo®,
Isoflurane, USP) via VetEquip Precision Vaporizer hooked up to an oxygen source.

Anesthesia was monitored by pinna reflex, pedal reflex, and corneal blink reflexes.

Eye lubricant, a sodium chloride eye drop solution, was applied to the eyes during
anesthesia and surgery. The implant site was the dorsal scapular region of the animal.
Aseptic technique was strictly adhered to during surgery as well as pre- and postoperation to assure the animals did not get an infection. The implant site was shaved,
cleaned using chlorhexidine solution, and 70% alcohol for sterilization before surgery.
An incision was made in the scapular region and a space slightly bigger than the pump
was created under the skin using a dull surgical instrument that will not lacerate,

puncture, or injure any surrounding tissue. The pump was placed subcutaneously in
the space with the flow moderator facing away from the incision. The incision was
closed with a synthetic, absorbable suture made of polyglycolic acid and surgical
sealant.

The animals were placed in their cages post-operation and monitored to

ensure recovery and overall health. Cageside observations were conducted twice daily
to observe the overall health of animals and to ensure that water and food were readily
available to the animals throughout the study.

Phase I: Establishment

This study phase included a normal control group of animals without implanted

pumps (n = 3) and a second control group of animals with pumps delivering vehicle (n
= 5). A third group of animals (n = 5) induced with scopolamine will also be included

(Refer to Table 1). The Alzet® model 2ML4 (lot number 10232-09) delivery rate is
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2.5 uL/hour. Two extra animals were ordered to assure healthy animals were

available for the study. Thus, a total of 15 female Lewis rats were used for this phase
of the study.

Phase II: Validation

This phase included two negative control groups including a group without
pump implantations and a group with pump implantations but received saline solution
instead of scopolamine. A third control group was implanted with pumps delivering
scopolamine and treated with the topical vehicle, saline solution. The fourth group of

animals was implanted with pumps delivering scopolamine and treated with Restasis®,
a commercially available dry eye medication, while the remaining group was implanted
with pumps delivering scopolamine and treated with a commercial product containing
dexamethasone. Dexamethasone is a corticosteroid. It is a long-acting analog that has

minimal mineralocorticoid activity and maximal anti-inflammatory activity. Its primary

use is to induce strong anti-inflammatory therapy acutely (45). The osmotic pump
delivery rate was 2.80 uL/hr, based on the manufacturer's supplied information for this
lot of pumps. Fluorometholone (FML) was the selected corticosteroid and was used
as secondary steroidal anti-inflammatory medication. The saline eye drops, Restasis®,
and FML were dosed on Days 0-28 (Refer to Table 2). All articles were administered

with a micropipette at a volume of 50 microliters/eye/dose into both eyes of each
animal. Three extra animals were ordered to assure healthy animals were available for
the study. Thus, a total of 26 female Lewis rats were used for this phase of the study.
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Clinical Examinations (All Phases)

The clinical signs of dry eye were evaluated by tear volume measurements with
sterilized phenol-red thread (FCI Opthalmics Zone Quick™), corneal staining with
0.2% sodium fluorescein (Novartis Pharmaceutials), and corneal thickness.

The animals were anesthetized prior to ocular assessments using isoflurane

vapors to effect. An integrated multi-patient anesthesia system (VetEquip IMPAC6
Complete Anesthesia System) with isoflurane vaporizer attachment was used to sedate
the animals prior to examination. Anesthesia was monitored by pinna reflex, pedal
reflex, and/or corneal blink reflexes.

Tear Volume

Tear volume measurements were performed using phenol-red threads and
recorded. A phenol-red impregnated thread will be applied to the ocular surface in the
lateral canthus for at least thirty seconds.

The bottom eyelid was abducted from the eye using forceps and the thread was
placed in the lateral canthus with blunt forceps. Once the thread was in the correct
position, the bottom eyelid was released from the forceps and allowed to hold the

thread in place for thirty seconds. The length of the wetted thread was measured using
an included scale provided in millimeters.

Corneal Staining
Image Collection

Immediately following tear volume measurements, clinical signs of corneal
dryness were evaluated utilizing fluorescein staining.

One drop of 0.2% sodium
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fluorescein was placed in the upper conjunctival sac of the right eye and allowed to
impregnate the cornea.

After two minutes, the eye was rinsed liberally with

ophthalmic eye wash (0.9% saline).

The cornea was then evaluated using

photographic slit lamp under cobalt blue light (Heidelberg Engineering). To quantify
the fluorescein impregnation, the cornea was observed using confocal scanning-laser
ophthalmoscopy (cSLO) at 488 nm with a Heidelberg Retinal Angiograph (HRA)
(Heidelberg Engineering). Corneal hydration was maintained with saline-type eye

drops as needed. The Heidelberg cSLO was used under the following settings: 15°, 50

diopters (D), and sensitivity 50. Images were later exported in Joint Photographic

Group (JPG) format for offline processing using ImageJ (National Institutes of Health)
and Matlab software programs.
Image Processing

JPG images were opened in ImageJ and a predetermined ROI circle (area =
289,632 pixels) was placed and centered manually. All pixels outside the ROI were
cleared and the altered image was saved (see Figure 1

Figure 1 Example of Image Captured with the Heidelberg cSLO: Before (left) and
after (right) subtraction of data outside of the ROI (scale bar in bottom
left corner set at 200 urn)
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Using Matlab, the background fluorescence haze was subtracted from the

altered images (threshold = 50). The mean image intensity as well as the remaining
area stained was calculated (sum of all non-zero pixels). The images were graded

automatically using the scoring system suggested by Viau, et.al. (2008) (1), who also
used the Heidelberg cSLO for corneal staining measurements. For each animal, the
ratio of fluorescent-positive area to total area of the ocular surface was calculated on

one picture, using Matlab in a masked fashion. The ratio was denoted as grade 0
when there was no staining, grade 0.5 when less than 5% was stained, grade 1 when
less than 10% was stained, grade 2 when less than 20% was stained, grade 3 when less
than 40% was stained, and grade 4 when 40% or more was stained (see Figure 2). The
mean was also calculated for each group of animals.

Score: 1

Score: 2
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Score: 3

Score: 4

Figure 2 Examples of Corneal Staining Scores
Corneal Thickness

Corneal thickness was measured immediately following fluorescein corneal
staining. OCT images of the central cornea were collected with the Heidelberg cSLO
using an additional 80D lens, 30° viewing angle, and 40D camera focus. Images were
exported using ImageJ and four land markers were noted allowing for measurement of
the air-tear film-epithelium interface (1-2), epithelium (2-3), and stroma (3-4) (see
Figure 3). Positions of markers were saved and thickness of each layer was measured

in pixels and calculated using Matlab.
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Figure 3 OCT with Placement of Markers

Euthanasia and Tissue Collection

All animals were euthanized via carbon dioxide inhalation and death was

verified by exsanguination via the abdominal vena cava. The cornea, conjunctiva, and

lacrimal gland were collected from the right eye of all animals at the end of each phase
of the study.

The harvested tissues were fixed in KNAlater® solution (Life

Technologies, Ambion) and refrigerated at 4°C for at least twenty-four hours before
they were transferred to a -20°C freezer where they can be held indefinitely. These
tissues were harvested for future molecular testing.

Statistics

Statistical analysis will be performed using ANOVA and calculated using
Matlab and MiniTab.

P values of less than 0.05 were considered statistically

significant. Grouping information using the Tukey method was used to determine
significant difference among groups.
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RESULTS

Phase I: Establishment

Tear Volume

The objective of this experiment was to see if tear production was reduced in

the group being administered scopolamine as compared to the control/untreated group
and the group being administered saline.

A shorter wetted thread length would

indicate low tear production and a longer wetted thread length would indicate high

tear production. Results of tear volume measurements of control animals, animals
implanted with saline- and scopolamine-filled pumps are illustrated in Figure 4.
Tear Volume
Phenol Read Thread

10

15

20

Days Post Implantation

Figure 4 Phase I: Tear Volume as Measured Using Wetted Zone Quick Phenol-Red
Thread

The results in Figure 4 indicate that there is a reduction in tear volume in the
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scopolamine treated group. At the beginning of the experiment on Day 0, the average
wetted thread length for this group was approximately 21 mm while at the end of the
experiment on Day 28, the average wetted thread length was 7.3 mm.

One-way

ANOVA was run using MiniTab and P = 0.000 was calculated which indicates

statistical significance among the groups. Grouping information using the Tukey
method was used to determine significant difference among groups (see Table 3).

N

Mean

Grouping*

Control

36

17.056

A

Saline

60

15.833

A

Scopolamine

60

10.533

B

*Means that do not share a letter are significantly different.
Table 3

Grouping Information Using Tukey Method: Phase I - Tear Volume (mm)
As indicated by the Tukey calculations, there was a significant difference
between the control and saline groups as compared to the scopolamine treated groups.

The results from this experiment indicate that tear volume was reduced in the
scopolamine treated groups.
Corneal Staining

Immediately following tear volume measurements, clinical signs of corneal

dryness were evaluated utilizing fluorescein staining. One drop of 0.2% sodium
fluorescein was placed in the upper conjunctival sac of the right eye and allowed to
impregnate the cornea. The cornea was then evaluated using photographic slit lamp
under cobalt blue light (Heidelberg Engineering).

To quantify the fluorescein

impregnation, the cornea was observed using confocal scanning-laser ophthalmoscopy
(cSLO) at 488 nm with a Heidelberg Retinal Angiograph (HRA) (Heidelberg
Engineering). JPG images were opened in ImageJ and a predetermined ROI circle
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(area = 289,632 pixels) was placed and centered manually. All pixels outside the ROI
were cleared and the altered image was saved as shown in Figure 1. Using Matlab, the

background fluorescence haze was subtracted from the altered images (threshold =
50). The mean image intensity as well as the remaining area stained was calculated
(sum of all non-zero pixels). The images were graded automatically using the scoring

system suggested by Viau, et.al. (2008), who also used the Heidelberg cSLO for
corneal staining measurements (1). For each animal, the ratio of fluorescent- positive
area to total area of the ocular surface was calculated on one picture, using Matlab in a

masked fashion. The ratio was denoted as grade 0 when there was no staining, grade
0.5 when less than 5% was stained, grade 1 when less than 10% was stained, grade 2

when less than 20% was stained, grade 3 when less than 40% was stained, and grade 4
when 40% or more was stained. Results of corneal staining measurements of control

animals, animals implanted with saline- and scopolamine-filled pumps are illustrated in
Figure 5.
Corneal Staining

r

25•.//

T

-Control

-Saline Pump

-Scopolamine Pump

i

Days Post Implantation

Figure 5 Phase I: Corneal Staining Measurements for All Groups across All Time
Points with "Area Stained" Based on Scale Rating of 1-4
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Corneal staining increased from about 1.5 - 2 in all groups to about 4 as the
study progressed and there was no difference in groups until Day 28 where the control

group seemed to spontaneously recover to around 1.5 as seen in Figure 5. One-way
ANOVA was run using MiniTab and P = 0.235 was calculated which indicates that

there was no statistical significance among the groups. Grouping information using
the Tukey method was used to determine significant difference among groups (see
Table 4).

N

Mean

Grouping*

Control

18
30

Scopolamine

30

84,900
110,681
115,532

A

Saline

A
A

*Means that do not share a letter are significantly different.
Table 4

Grouping Information Using Tukey Method: Phase I - Corneal Staining (pixels)
As indicated by the Tukey calculations, there was no significant difference
among the groups. The results from this experiment indicate that although there was a
tendency toward increased corneal staining among the groups, there was no actual

significant difference among the groups.
Corneal Thickness

Corneal thickness was measured immediately following fluorescein corneal
staining. OCT images of the central cornea were collected with the Heidelberg cSLO

using an additional 80D lens, 30° viewing angle, and 40D camera focus. Images were
exported using ImageJ and four land markers were noted allowing for measurement of
the air-tear film-epithelium interface (1-2), epithelium (2-3), and stroma (3-4) as

illustrated in Figure 3.

This experiment was designed to determine if there is a

relationship between corneal thickness and dry eye. For instance, I expected that
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corneal thickness would increase over the 28 day study in the scopolamine treated

group whereas the control group should have relatively no change in corneal thickness
over the course of the study.

The results of the tear film - epithelium interface thickness measurements
among all groups are illustrated in Figure 6.
Tear Film - Epithelial
InterfaceThickness
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Figure 6 Phase I: Tear Film - Epithelial Interface Thickness Measurements

As shown in the figure above, the tear film - epithelium interface thickness was
between 5 and 6 pixels for all groups at the beginning of the experiment and between
4.5 and 5 pixels at the end of the experiment. This is a very small change. One-way
ANOVA was run using MiniTab and P = 0.676 was calculated which indicates that

there was no statistical significance among the groups. Grouping information using
the Tukey method was used to determine significant difference among groups (see
Table 5).
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N

Mean

Grouping*

18

5.1394

A

Saline

30

5.0337

A

Scopolamine

30

5.2410

A

Control

*Means that do not share a letter are significantly different.
Table 5

Grouping Information Using Tukey Method: Phase I - Corneal Thickness - Tear
Film/Epithelium Interface (pixels)

As indicated by the Tukey calculations, there was no significant difference
among the groups.

The results from this experiment indicate that there was no

significant change in tear film - epithelium interface thickness.
The results of the epithelium thickness measurements among all groups are
illustrated in Figure 7.
Epithelium Thickness
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Figure 7 Phase I: Epithelium Thickness Measurements

As shown in the figure above, the epithelium thickness was between 6 and 6.5

pixels for all groups at the beginning of the experiment.

The scopolamine groups

decreased to about 4.5 pixels over the next two time points but recovered at the end of

the study and finished at about the same thickness as the beginning of the study. One-
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way ANOVA was run using MiniTab and P = 0.029 was calculated which indicates
that there was statistical significance among the groups. Grouping information using
the Tukey method was used to determine significant difference among groups (see
Table 6).

N

Mean

Grouping*

Control

18

6.649

A

Saline

30

6.521

A

5.906

A

Scopolamine

30

*Means that do not share a letter are significantly different.
Table 6

Grouping Information Using Tukey Method: Phase I - Corneal Thickness
Epithelium (pixels)

As indicated by the Tukey calculations, there was no significant difference
among the groups.

The results from this experiment indicate that the statistical

significance could be due to the drop in the epithelium thickness at Day 7 and Day 14
but throughout the course of the study the epithelium thickness was about the same
for all groups.

The results of the stroma thickness measurements among all groups are
illustrated in Figure 8.
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Stroma Thickness
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Figure 8 Phase I: Stroma Thickness Measurements

As shown in the figure above, the stroma thickness was around 30 pixels for all

groups at the beginning of the experiment and between 30 and 30.5 pixels at the end
of the experiment. This is a very small change. One-way ANOVA was run using
MiniTab and P = 0.664 was calculated which indicates that there was no statistical

significance among the groups. Grouping information using the Tukey method was
used to determine significant difference among groups (see Table 7).

N

Mean

Grouping*

Control

18

30.506

A

Saline

30

30.577

A

Scopolamine

30

30.093

A

*Means that do not share a letter are significantly different.
Table 7

Grouping Information Using Tukey Method: Phase I - Corneal Thickness - Stroma
(pixels)

As indicated by the Tukey calculations, there was no significant difference
among the groups. The results from this experiment indicate that there was no
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significant change in stroma thickness over the course of the study.
Phase II: Validation

Tear Volume

The objective of this experiment was to see if tear production was reduced in
the groups being administered scopolamine (one group not receiving treatment, one

group being treated with Restasis, and one group being treated with FML) as
compared to the control group. A shorter wetted thread length would indicate low
tear production and a longer wetted thread length would indicate high tear production.
Results of tear volume measurements all groups are illustrated in Figure 9.

Tear Volume
? 25
-•-•-

Control
UnTreated

-*-

Saline

-*-

Restasis
Steroid

Days Post Implantation

Figure 9 Phase II: Tear Volume as Measured Using Wetted Zone Quick Phenol-Red
Thread (mm)
The results in Figure 9 indicate that there is a reduction in tear volume in all
groups except the control group. At the beginning of the study on Day 0, the average
wetted thread length for all groups was approximately between 15 mm and 20 mm. At

the end of the study on Day 28, the average wetted thread length of the scopolaminetreated groups was between 5 mm and 10 mm while the control group was still around
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20 mm. One-way ANOVA was run using MiniTab and P = 0.000 was calculated
which indicates statistical significance among the groups. Grouping information using

the Tukey method was used to determine significant difference among groups (see
Table 8).

N

Mean

Grouping*

Control

36

16.806

A

Scopolamine Untreated
Saline Eye Drops
Restasis Eye Drops
FML Eye Drops

48

8.8333

B

60

10.450

B

60

9.600

B

60

9.917

B

*Means that do not share a letter are significantly different.
Table 8

Grouping Information Using Tukey Method: Phase II - Tear Volume (mm)
As shown by the Tukey calculations, there was a significant difference between

the control group and the scopolamine treated groups.

The results from this

experiment indicate that tear volume was reduced in the scopolamine treated groups.
Corneal Staining

Immediately following tear volume measurements, clinical signs of corneal
dryness were evaluated utilizing fluorescein staining.

One drop of 0.2% sodium

fluorescein was placed in the upper conjunctival sac of the right eye and allowed to

impregnate the cornea. The cornea was then evaluated using photographic slit lamp

under cobalt blue light (Heidelberg Engineering).

To quantify the fluorescein

impregnation, the cornea was observed using confocal scanning-laser ophthalmoscopy

(cSLO) at 488 nm with a Heidelberg Retinal Angiograph (HRA) (Heidelberg
Engineering). JPG images were opened in ImageJ and a predetermined ROI circle
(area = 289,632 pixels) was placed and centered manually. All pixels outside the ROI
were cleared and the altered image was saved as shown in Figure 1. Using Matlab, the
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background fluorescence haze was subtracted from the altered images (threshold =
50). The mean image intensity as well as the remaining area stained was calculated
(sum of all non-zero pixels). The images were graded automatically using the scoring

system suggested by Viau, et.al. (2008), who also used the Heidelberg cSLO for
corneal staining measurements. For each animal, the ratio of fluorescent- positive area
to total area of the ocular surface was calculated on one picture, using Matlab in a
masked fashion. The ratio was denoted as grade 0 when there was no staining, grade
0.5 when less than 5% was stained, grade 1 when less than 10% was stained, grade 2

when less than 20% was stained, grade 3 when less than 40% was stained, and grade 4
when 40% or more was stained. Results of corneal staining measurements pertaining

to area stained for all groups are illustrated in Figure 10.
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Figure 10 Phase II: Area Stained of Cornea in Pixels

All values for Day 14 were excluded from the data set due to inconsistent
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scoring among all groups. With the data from Day 14 excluded, corneal staining
among the groups treated with scopolamine were very similar throughout the study.
Corneal staining in the control group seemed to remain fairly consistent until the last
two weeks of the study where the staining spontaneously increased to around 65,000

pixels as seen in Figure 10. One-way ANOVA was run using MiniTab and P = 0.050
was calculated which indicates that there was no statistical significance among the

groups.

Grouping information using the Tukey method was used to determine

significant difference among groups (see Table 9).

N

Mean

Grouping*

Control

15

A

Scopolamine Untreated
Saline Eye Drops
Restasis Eye Drops
FML Eye Drops

22

21,015
5,640
5,540
2,084
5,540

♦Means that

25
25
25

AB
AB
B
AB

do not share a letter are significantly different.
Table 9

Grouping Information Using Tukey Method: Phase II - Corneal Staining - Area
Stained (pixels)

As indicated by the Tukey calculations, there was a significant difference
among the control group and the scopolamine group treated with Restasis drops.
Also, the results from the Tukey calculations indicate that there were similar corneal
staining amongst the scopolamine untreated group and scopolamine groups treated
with saline and FML drops. However, these three groups also shared similar statistical
significance with the control group as well as the scopolamine group treated with
Restasis drops. The results from this experiment indicate that there were inconsistent
results measuring corneal staining area.
Scoring results of corneal staining measurements for all groups are illustrated
in Figure 11.
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Figure 11 Phase II: Scoring Results of Corneal Staining

All values for Day 14 were excluded from the data set due to inconsistent
scoring among all groups.

With the data from Day 14 excluded, corneal staining

among the groups treated with scopolamine was very similar throughout the study.
Corneal staining in the control group seemed to remain fairly consistent until the last
two weeks of the study where the staining spontaneously increased to a score of
around 2 as seen in Figure 11. One-way ANOVA was run using MiniTab and P =
0.128 was calculated which indicates that there was no statistical significance among
the groups.

Grouping information using the Tukey method was used to determine

significant difference among groups (see Table 10).
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N

Mean

Grouping*

Control

15

0.9667

A

Scopolamine Untreated
Saline Eye Drops
Restasis Eye Drops
FML Eye Drops

22

0.5682

A

25

0.6000

A

25

0.5000

A

25

0.6800

A

♦Means

that do not share a letter are significantly different.
Table 10

Grouping Information Using Tukey Method: Phase II - Corneal Staining - Area
Scored

As indicated by the Tukey calculations, there was no significant difference
among the groups.

The results from this experiment indicate that there was no

significant difference in regards to corneal staining scores among the test groups.

Corneal Thickness

Corneal thickness was measured immediately following fluorescein corneal
staining. OCT images of the central cornea were collected with the Heidelberg cSLO

using an additional 80D lens, 30° viewing angle, and 40D camera focus. Images were
exported using ImageJ and four land markers were noted allowing for measurement of
the air-tear film-epithelium interface (1-2), epithelium (2-3), and stroma (3-4) as
illustrated in Figure 3.

This experiment is trying to see if there is a relationship

between corneal thickness and dry eye.

For instance, it would be expected that

corneal thickness would increase over the 28 day study in the scopolamine-untreated
group whereas the control group should have relatively no change in corneal thickness
over the course of the study.

The results of the tear film - epithelium interface thickness measurements
among all groups are illustrated in Figure 12.
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Figure 12 Phase II: Tear Film - Epithelial Interface Thickness Measurements

As shown in the figure above, the tear film - epithelium interface thickness
measurements were up and down for all groups throughout the course of the study.
One-way ANOVA was run using MiniTab and P = 0.073 was calculated which
indicates that there was no statistical significance among the groups.

Grouping

information using the Tukey method was used to determine significant difference
among groups and shown in Table 11.

N

Mean

Grouping*

Control

18

6.189

A

Scopolamine Untreated
Saline Eye Drops
Restasis Eye Drops
FML Eye Drops

26

5.742

A

30

5.433

A

30

5.367

A

30

5.401

A

*Means that do not share a letter are significantly different.
Table 11

Grouping Information Using Tukey Method: Phase II - Corneal Thickness - Tear
Film/Epithelium Interface (pixels)
As indicated by the Tukey calculations, there was no significant difference
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among the groups.

The results from this experiment indicate that there was no

significant change in tear film - epithelium interface thickness.

The results of the epithelium thickness measurements among all groups
are illustrated in Figure 13.
Epithelium Thickness
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Figure 13 Phase II: Epithelium Thickness Measurements

As shown in the figure above, the epithelium thickness reduces sharply on Day
2 and stays between 3-4 pixels thick for the remainder of the study. This is in contrast

to the rest of the groups who remain between 5-6 pixels throughout the study. One
way ANOVA was run using MiniTab and P = 0.000 was calculated which indicates

that there was statistical significance among the groups. Grouping information using
the Tukey method was used to determine significant difference among groups and (see
Table 12).
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Mean

Grouping*

18

5.318

A

26

5.547

A

30

5.406

A

30

5.262

A

30

3.935

B

N

Control

Scopolamine Untreated
Saline Eye Drops
Restasis Eye Drops
FML Eye Drops
♦Means

that do not share a letter are significantly different.
Table 12

Grouping Information Using Tukey Method: Phase II - Corneal Thickness Epithelium (pixels)

As indicated by the Tukey calculations, there was a significant difference
between the FML-treated group when compared to all other groups on study. The

results from this experiment indicate that FML has an effect on the thickness of the
corneal epithelium and more specifically results in a thinning of the epithelium.
The results of the stroma thickness measurements among all groups are
illustrated in Figure 14.

Stroma Thickness

-Control

-Scopolamine Untreated
Saline

-Restasis

Steroid

Days Post Implantation

Figure 14 Phase II: Stroma Thickness Measurements
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As shown in the figure above, the stroma thickness was around 30 pixelsfor all
groups except throughout the study except for the steroid-treated group. The steroidtreated group started at 30 pixels and decreased to about 24 pixels by the end of the

study. One-way ANOVAwas run using MiniTab and P = 0.001 was calculated which
indicates that there was statistical significance among the groups.

Grouping

information using the Tukey method was used to determine significant difference
among groups (see Table 13).

N

Mean

Grouping*

Control

18

29.489

A

Scopolamine Untreated
Saline Eye Drops
Restasis Eye Drops
FML Eye Drops

26

29.532

A

30

29.246

A

30

28.649

A

30

25.455

B

♦Means

that do not share a letter are significantly different.
Table 13

Grouping Information Using Tukey Method: Phase II - Corneal Thickness - Stroma
(pixels)

As indicated by the Tukey calculations, there was a significant difference

between the FML-treated group when compared to all other groups on study. The
results from this experiment indicate that FML has an effect on the thickness of the
stroma and more specificallyresults in a thinning of the stroma.
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DISCUSSION

In Phase I, animals receiving scopolamine had a reduction in tear volume as

early as 2 days after pump implantation and saline treated or control animals did not
have similar tear reduction. All groups had increased corneal staining and there was

no significant difference in corneal thickness between groups. While tear production

was decreased in animals that received scopolamine, corneal staining was significantly
increased in all animals on study. Corneal thickness is not commonly reported in dry

eye exams, but studies where this has been reported have seen a thinning of the cornea
with dry eye severity (46). Since all animals had increased corneal staining, future
studies should include a validation study to determine if treatment with Restasis, FML,
or saline will alleviate dry eye symptoms.

In Phase II, the model was validated using topical saline, steroid, or Restasis.
All groups receiving scopolamine via osmotic pump had a reduction in tear volume
within five days. Tear volume did not increase over the course of the study which

indicates that the saline drops, Restasis, and steroid were not successful in recovering
tear production. There was no significant difference among control and test groups in
the corneal staining assessments.

This study demonstrated continuous systemic administration of scopolamine to
female Lewis rats and resulted in reduced tear volumes as measured during the 28 days

following pump implantations. Thinning of the epithelium and stroma of the steroidtreated group indicates that dry eye was evident in Phase II, however, FML may not

be as effective of a treatment as compared to saline drops or Restasis. FML caused
the inflammatory response to decrease but it also may have caused important
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biological functions in the corneal cells to cease such as a quick turnover rate which
could contribute to the thinning and pathogenesis seen in dry eye. Fluorescein corneal

staining was increased, although high inter-animal variability prohibited definitive
group comparisons. For example, on Day 14 the animals receiving Restasis treatment

had a spike in their corneal staining score to about 2 but decreased back to a score of
0.5 on Day 21. Looking at the data, all animals in that group averaged a score of
about 0.5 for the duration of the study except on Day 14; three animals had scores of

2, 3, and 4, respectively, which skewed the results. If more animals were on study,
these outliers would not have had as great of an impact on the data and altering of the
results. The data is shown below in Table 10 with outliers highlighted in red.

DayO

Day 2

Day 7

Day 14

Day 21

Day 28
0.5

4014

0.5

0.5

0.5

4

0.5

4015

0.5

0.5

0.5

3

0.5

1

4016

0.5

0.5

0.5

0.5

0.5

0.5

4017

0.5

0.5

0.5

1

0.5

0.5

4018

0.5

0

0.5

2

0.5

0.5

0.5

0.4

0.5

2.1

0.5

0.6

Average
Score

Table 14

Scores of Corneal Staining in Phase II Restasis Treated Groups
Environmental factors also need to be taken into consideration when looking at

the corneal staining data. The urea levels from urine could play a factor in corneal

staining. Higher levels of urea could have a significant factor in affecting tear film
homeostasis. The bedding that the rats had in their cages may have played a factor in
the highly variable corneal staining scores because it could have scratched their eyes
and contributed to higher urea levels. The cages should be swapped out for
metabolism cages in future studies so that all of the feces and urine would be collected
outside of the cage and all environmental factors such as temperature and humidity
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could be completely controlled.

This study is a step in the right direction as far as studying the acute effects of
dry eye and to discover the best ways to diagnose and treat the condition. However, it

is limited in the length of time you can actually study the animals because the osmotic
pumps only have 28 days of scopolamine administration. A model using genetically
engineered rats could be developed to observe the effects of dry eye over a longer
period of time and mimic the chronicity seen in many human patients. Spontaneous

development of dry eye due to specific endocrine imbalance has not been shown in any
animal models to date. Nevertheless, orchiectomy and ovariectomy in rabbits, rats,
mice, guinea pigs, and hamsters, and hypophysectomy in rats, have been used as

models to study the influence of hormones on the structure and function of the lacrimal
and meibomian glands (3). These procedures are not meant as an exact mimic of dry

eye, but to decipher important pathogenic aspects of tear film regulation. Hormones
have both direct and indirect effects on exocrine tissues due to their capacity to
regulate immunity as well as the gene expression of many secreted molecules. For
example, Sullivan, et. al. (2002), have demonstrated that androgens regulate the

function of lacrimal glands and the quantity, quality, and metabolism of the lipid layer
of the tear film produced by the meibomian glands (33). This may be an indication

why women in the U.S. over the age of 50 display increased signs of dry eye because
they have gone through menopause which causes a change in estrogen levels.
Genetically modified mice are expected to aid in the study of the influence of a specific
hormone(s) on the tear film homeostasis (3). Also, a naturally occurring model seen in
rabbits or dogs could be a better model because many variables are eliminated, such as

effect of scopolamine on the rest of the body, and would allow researchers to better
gauge the natural progression of dry eye. Since scopolamine has no preference for one
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of the different muscarinic subtypes, scopolamine will block the effects of

acetylcholine at the muscarinic receptor throughout the body and brain and affect
various physiological functions (43). It is not known what kind of effect or effectsthis
would have during a dry eye study but it is a variable that needs to be taken into
consideration when evaluating which model to use.

Another important aspect of the tear film that needs to be researched in further

detail is the lipid layer. This is the outermost layer of the tear film and protects the

aqueous layerfrom evaporating. It has been proven that artificial tears can offer relief
to dry eye but not improve the underlying conditions that cause the disease. The key
in discovering a cure for this disease could lie in how to control the lipid content of the
tear film and how its secretion from the meibomian gland is controlled.

A novel aspect to this research study is the introduction of Restasis and FML
to the model. It is important to see if these compounds that are used to treat the

condition in humans have any effect on improving the symptoms of dry eye in animals
so the model can be used to study new pharmacological treatments. Also, the OCT

imaging and histological slices allow for us to look at cross sections of tissue in vivo.

These images help to identify any changes in thinning of the cornea which has been
revealed by Liu, et. al. (1999) to be an indicator of dry eye (46). Another benefit of
the OCT imaging is that animals do not have to be sacrificed to look at cross sections
of the cornea. This allows for better continuity in the study because data is being

generated from the same animals across numerous time points.
Future studies would include molecular diagnostic methods. Harvesting tissue
such as the cornea, conjunctiva, and lacrimal gland and then running mRNA analyses
to compare protein production among tissues and groups would be a great addition to
this model. The mRNA analysis could potentially identify biomarkers indicative of the
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condition. For example, increased histamine levels in animals with dry eye could
indicate an immune response and lead to a chemical cascade of other immunological

agents. These protein levels of dry eye-induced animals and control animals could be

compared side-by-side to help identify what's happening at a molecular level and
categorize the severity of these reactions in regards to their contribution to dry eye
symptoms.

I would also add some histology procedures to the study. Hematoxylin

and eosin staining would provide some basic front-line diagnostics and help identify
any structural damage.

Immunohistochemical techniques could help identify the

locations of some of the biomarkers found in the mRNA analysis.

The scopolamine-induced dry eye model is a fairly new method of identifying
clinical signs of dry eye. Research conducted by Viau, et. al. (2008) was the primary
literature on which this study was based. Our model of dry eye does not include the

molecular methods as used by Viau but they also did not use any means of measuring
aqueous tear production (1).

A 12.5 mg/day dose of scopolamine was used as

recommended by Viau because it induced a moderate form of dry eye that is mainly
seen in humans.

A 25 mg/day dose was used in their study but induced a sever

condition that is uncommon in humans.

Another difference was Viau looked at a

number of mucins and immuno-factors that are involved in the progression of dry eye
but these hold no value in diagnosing the condition in a live patient.

The results from the fluorscein staining were mixed in comparison. Viau's dry

eye animals averaged a score of 2.5 over three recorded time points whereas this
study's scopolamine-induced dry eye animals averaged a score of around 3.5 over six
time points. Viau's study is a great foundation for establishing a dry eye model but it
has no clinical relevance. This study needs refining but there is more pure diagnostic
value that can be used from tear volume measurements and in vivo cross sections of
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the cornea.

Clinical Implications

This pre-clinical dry eye model is transferable as a clinical dry eye model. If a

patient schedules an appointment with their eye doctor and is complaining of
symptoms analogous to dry eye, the doctor can run a battery of tests to help quickly
and accurately diagnose the condition. First, they can place piece of phenol-red thread

in each eye to determine tear volume. Next, they can place drops of fluorscein in each
eye and record images of the corneal surface using cSLO. Then, they can look at a
cross-section of the patient's eye using OCT to identify any thinning of the cornea
without the need of a tissue sample. All of these procedures are non-invasive and can

be performed in a matter of minutes at a clinic. If enough data is available, the doctor

could compare the results of the tests to proven dry eye data and start the patient on
treatment if necessary.

Synopsis

In

summary,

these

experiments

demonstrated

continuous

systemic

administration of scopolamine to female Lewis rats and resulted in reduced tear

volumes as measured during the 28 days following pump implantations. Thinning of
the epithelium and stroma of the steroid-treated group indicates that dry eye was
evident in Phase II, however, FML may not be as effective of a treatment as compared
to saline drops or Restasis. Fluorescein corneal staining was increased, although high
inter-animal variability prohibited definitive group comparisons. Furthermore, these
experiments make a contribution to the field of dry eye study.
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